英国の感染症検査市場の見通し：成長機会と事業拡大戦略

当レポートでは、英国の感染症検査市場について調査分析し、世界市場と技術の概要、英国市場の現状と今後10年間の将来予測を提供するほか、主な製品開発機会、市場参入戦略などを検証し、主要企業プロファイルも含め、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術の概要

• 主な感染症検査
  • エイズ
  • アデノウィルス
  • エロモナス
  • 炭疽病
  • アルボウイルス
  • バベシア症
  • 細菌性血管腫症・バルトネラ類感染症
  • ブラストシスチスホミニス
  • ブルセラ症
  • カンピロバクター
  • カンジダ症
  • シャーガス病
  • 軟性下疳
  • クラミジア
  • クロストリジウムディフィシレ感染症
  • コロナウイルス
  • コクサッキーウイルス、など
• 装置レビューと市場ニーズ
• 新興の診断技術
  • DNAプローブ
  • モノクローナル抗体
  • イムノアッセイ
  • 差分光拡散
  • マイクロコンピューター、オートメーション
  • 人工知能
  • リポソーム
  • フローサイトメトリー
  • クロマトグラフィー
  • MRI
  • ゲルマイクロドロップ法
  • その他

英国市場

• エグゼクティブサマリー
• ビジネス環境
• 市場構造
• 市場規模と成長、主要サプライヤー

主な製品開発機会

• 機器
• 試薬キットと検査システム/パネル
• コンピューター、ソフトウェア、オートメーション
• 補助製品

分散型検査製品の設計基準

市場参入戦略

• 国内開発
• 共同開発
• 大学との契約
• 流通戦略

潜在的な市場参入障壁とリスク

• 市場の成熟
• 費用抑制
• 競合
• 技術面での優位性と限界
• 特許権保護
• 規制上の制約
• 分散型検査市場の課題

競合企業各社の評価

図表

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

This report presents a comprehensive analysis of the UK infectious disease testing market, including:

• Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in UK hospitals, blood banks, public health and commercial laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Introduction

Worldwide Market and Technology Overview

• A. Major Infectious Disease Tests
  • 1. AIDS
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
• B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
• C. Emerging Diagnostic Technologies
  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

U.K.

• A. Executive Summary
• B. Business Environment
• C. Market Structure
• D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

• A. Instrumentation
• B. Reagent Kits and Test Systems/Panels
• C. Computers, Software and Automation
• D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

• A. Internal Development
• B. Collaborative Arrangements
• C. University Contracts
• D. Distribution Strategies for Decentralized Testing Markets
  • 1. Marketing Approaches
  • 2. Product Complexity
  • 3. Customer Preference
  • 4. Established Suppliers
  • 5. Emerging Suppliers
  • 6. Major Types of Distributors
  • 7. Market Segmentation

Potential Market Entry Barriers and Risks

• A. Market Maturity
• B. Cost Containment
• C. Competition
• D. Technological Edge and Limitations
• E. Patent Protection
• F. Regulatory Constraints
• G. Decentralized Testing Market Challenges

Competitive Assessments

• Abbott
• Affymetrix
• Beckman Coulter/Danaher
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Cepheid
• Diamedix
• DiaSorin
• Eiken Chemical
• Enzo Biochem
• Fujirebio
• Gen-Probe
• Hologic
• ID Biomedical
• Innogenetics/Solvay
• Kreatech
• Life Technology
• Lonza
• Nanogen/Elitech
• Novartis Diagnostics
• Ortho-Clinical Diagnostics
• Qiagen
• Roche
• Scienion
• Sequenom
• SeraCare
• Siemens
• Takara Bio
• Thermo Fisher
• Wallac
• Wako

• Major Companies Developing or Marketing AIDS Tests
• Major Companies Developing or Marketing Adenovirus Tests
• Major Companies Developing or Marketing Bartonella Tests
• Major Companies Developing or Marketing Campylobacter Tests
• Major Companies Developing or Marketing Candida Tests
• Major Companies Developing or Marketing Chlamydia Tests
• Major Companies Developing or Marketing Clostridium Tests
• Major Companies Developing or Marketing Coronavirus Tests
• Major Companies Developing or Marketing Cryptosporidium Tests
• Major Companies Developing or Marketing CMV Tests
• Major Companies Developing or Marketing Echovirus Tests
• Major Companies Developing or Marketing Enterovirus Tests
• Major Companies Developing or Marketing EBV Tests
• Major Companies Developing or Marketing Giardia Tests
• Major Companies Developing or Marketing Gonorrhea Tests
• Major Companies Developing or Marketing Hantavirus Tests
• Major Companies Developing or Marketing Helicobacter Pylori Tests
• Major Companies Developing or Marketing Hepatitis Tests
• Major Companies Developing or Marketing Herpes Tests
• Major Companies Developing or Marketing Influenza Tests
• Major Companies Developing or Marketing Legionella Tests
• Major Companies Developing or Marketing Lyme Disease Tests
• Major Companies Developing or Marketing Lymphogranuloma Tests
• Major Companies Developing or Marketing Malaria Tests
• Major Companies Developing or Marketing Measles Tests
• Major Companies Developing or Marketing Meningitis Tests
• Major Companies Developing or Marketing Microsporidium Tests
• Major Companies Developing or Marketing Mononucleosis Tests
• Major Companies Developing or Marketing Mumps Tests
• Major Companies Developing or Marketing Mycoplasma Tests
• Major Companies Developing or Marketing Papilloma Virus Tests
• Major Companies Developing or Marketing Parvovirus Tests
• Major Companies Developing or Marketing Pneumonia Tests
• Major Companies Developing or Marketing RSV Tests
• Major Companies Developing or Marketing Rotavirus Tests
• Major Companies Developing or Marketing Rubella Tests
• Major Companies Developing or Marketing Salmonella Tests
• Major Companies Developing or Marketing Septicemia Tests
• Major Companies Developing or Marketing Shigella Tests
• Major Companies Developing or Marketing Staphylococci Tests
• Major Companies Developing or Marketing Streptococci Tests
• Major Companies Developing or Marketing Syphilis Tests
• Major Companies Developing or Marketing Toxoplasmosis Tests
• Major Companies Developing or Marketing Trichomonas Tests
• Major Companies Developing or Marketing Tuberculosis Tests
• Major Companies Developing or Marketing West Nile Tests
• Major Companies Developing or Marketing Yersinia Tests

• U.K. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Laboratories Performing Infectious Disease Tests by Market Segment
• U.K. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
• U.K. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
• U.K. All Market Segments Infectious Disease Test Volume Forecast
• U.K. Hospital Laboratories Infectious Disease Test Volume Forecast
• U.K. Blood Banks Infectious Disease Test Volume Forecast
• U.K. Public Health Laboratories Infectious Disease Test Volume Forecast
• U.K. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
• U.K. All Market Segments Infectious Disease Diagnostics Market Forecast
• U.K. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
• U.K. Blood Banks Infectious Disease Diagnostics Market Forecast
• U.K. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
• U.K. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
• U.K. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.K. AIDS Testing Market Diagnostics Sales by Major Supplier
• U.K. Campylobacter Testing Market Diagnostics Sales by Major Supplier
• U.K. Candida Testing Market Diagnostics Sales by Major Supplier
• U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
• U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
• U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
• U.K. Influenza Testing Market Diagnostics Sales by Major Supplier
• U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
• U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
• U.K. RSV Testing Market Diagnostics Sales by Major Supplier
• U.K. Rubella Testing Market Diagnostics Sales by Major Supplier
• U.K. Septicemia Testing Market Diagnostics Sales by Major Supplier
• U.K. Shigella Testing Market Diagnostics Sales by Major Supplier
• U.K. Streptococci Testing Market Diagnostics Sales by Major Supplier
• U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier
• U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier